Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001373604-25-000043·BML Investment Partners, L.P.
Schedule 13G ownership disclosure
LAVA THERAPEUTICS NV
Common shares, par value $0.14 per share · CUSIP: N51517105
Event date: 2025-02-26
- Filing-level shares
- 1,958,110
- Percent of class
- 7.4%
- BML Investment Partners, L.P.
Shares: 1,958,110 · Class: 7.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000043
- Form type
- SCHEDULE 13G
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Mar 03, 2025
- Reporting period
- Feb 26, 2025
- Description
- Schedule 13G beneficial ownership